125 related articles for article (PubMed ID: 3008020)
1. Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.
Grossman A; Moult PJ; Cunnah D; Besser M
Neuroendocrinology; 1986; 42(4):357-60. PubMed ID: 3008020
[TBL] [Abstract][Full Text] [Related]
2. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
Leposavic G; Cover PO; Buckingham JC
Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
[TBL] [Abstract][Full Text] [Related]
4. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist.
Ehrenreich H; Kolmar C; Müller OA; Goebel FD
Klin Wochenschr; 1987 May; 65(10):453-7. PubMed ID: 3037181
[TBL] [Abstract][Full Text] [Related]
6. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
Rushen J; Schwarze N; Ladewig J; Foxcroft G
Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
8. Effect of captopril, an inhibitor of the converting enzyme on naloxone induced secretion of ACTH and LH in man.
Palermo M; Oliva O; Pala A; Delitala G
Horm Metab Res; 1993 Oct; 25(10):536-8. PubMed ID: 8262463
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol.
Xiao E; Xia L; Shanen D; Khabele D; Ferin M
Endocrinology; 1994 Nov; 135(5):2093-8. PubMed ID: 7956932
[TBL] [Abstract][Full Text] [Related]
10. Endocrine actions of opioids.
Pfeiffer A; Herz A
Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women.
Loucks AB; Mortola JF; Girton L; Yen SS
J Clin Endocrinol Metab; 1989 Feb; 68(2):402-11. PubMed ID: 2537332
[TBL] [Abstract][Full Text] [Related]
12. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[TBL] [Abstract][Full Text] [Related]
14. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
Delitala G; Trainer PJ; Oliva O; Fanciulli G; Grossman AB
J Endocrinol; 1994 Apr; 141(1):163-8. PubMed ID: 8031419
[TBL] [Abstract][Full Text] [Related]
15. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
[TBL] [Abstract][Full Text] [Related]
16. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
17. Influence of endogenous opiates on anterior pituitary function.
Van Vugt DA; Meites J
Fed Proc; 1980 Jun; 39(8):2533-8. PubMed ID: 6247213
[TBL] [Abstract][Full Text] [Related]
18. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
Wand GS; Weerts EM; Kuwabara H; Wong DF; Xu X; McCaul ME
Addict Biol; 2013 Jan; 18(1):181-92. PubMed ID: 22264217
[TBL] [Abstract][Full Text] [Related]
19. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
20. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
Scott LV; Burnett F; Medbak S; Dinan TG
Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
